Pfizer RSV vaccine data submitted to FDA for evaluation. Large international study found vaccinating during pregnancy was nearly 82% effective at preventing severe RSV cases in their babies’ first 90 days of life, 69% at 6 months.

Medical Mythbusting Commentary for November 2, 2022

Strong RSV vaccine data lifts hopes after years of futility